The Current Ratio as of December 2025 (TTM) for Integrated Diagnostics Holdings plc (IDGXF) is 1.53

According to Integrated Diagnostics Holdings plc’s latest financial reports and current stock price. The company's current Current Ratio is 1.53. This represents a change of 3.64% compared to the average of 1.48 of the last 4 quarters.

Integrated Diagnostics Holdings plc (IDGXF) Historical Current Ratio (quarterly & annually)

How has IDGXF Current Ratio performed in the past?

The mean historical Current Ratio of Integrated Diagnostics Holdings plc over the last ten years is 1.52. The current 1.53 Current Ratio has changed 9.99% with respect to the historical average. Over the past ten years (40 quarters), IDGXF's Current Ratio was at its highest in in the December 2016 quarter at 2.03. The Current Ratio was at its lowest in in the September 2015 quarter at 0.

Integrated Diagnostics Holdings plc (IDGXF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Integrated Diagnostics Holdings plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Integrated Diagnostics Holdings plc (IDGXF) Average Current Ratio

How has IDGXF Current Ratio performed in the past?

The current Current Ratio of Integrated Diagnostics Holdings plc (IDGXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Integrated Diagnostics Holdings plc (IDGXF) Current Ratio vs. Peers

How is IDGXF’s Current Ratio compared to its peers?

Integrated Diagnostics Holdings plc’s Current Ratio is greater than iSpecimen Inc. (0.63), less than Star Equity Holdings, Inc. (2.07), greater than bioAffinity Technologies, Inc. (0.64), less than Applied DNA Sciences, Inc. (2.76), less than Sera Prognostics, Inc. (1.89), greater than Precipio, Inc. (1.27), greater than Genetic Technologies Limited (0.88), greater than MDxHealth S.A. (1.14), less than Star Equity Holdings, Inc. (2.07), less than Standard BioTools Inc. (4.38), less than Genetron Holdings Limited (1.82), less than Biodesix, Inc. (1.84), greater than ENDRA Life Sciences Inc. (1.31), less than HTG Molecular Diagnostics, Inc. (1.89), greater than Intelligent Bio Solutions Inc. (0.77), greater than bioAffinity Technologies, Inc. (0.64), greater than SeqLL Inc. (1.23), greater than Interpace Biosciences, Inc. (1.33), less than Neuronetics, Inc. (2.24), greater than ProPhase Labs, Inc. (0.14),

Build a custom stock screener for Integrated Diagnostics Holdings plc (IDGXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Integrated Diagnostics Holdings plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Integrated Diagnostics Holdings plc (IDGXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Integrated Diagnostics Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.